Inflammasome Therapeutics

Newton, United States

Inflammasome Therapeutics develops therapies for prevalent, degenerative diseases like Alzheimer’s disease and Parkinson's disease.

$2.5M raised

May 2026

Venture - Series Unknown

Biotechnology Health Care Therapeutics

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Inflammasome Therapeutics

How much funding has Inflammasome Therapeutics raised?

Inflammasome Therapeutics has raised $2.5M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in May 2026.

Where is Inflammasome Therapeutics headquartered?

Inflammasome Therapeutics is headquartered in Newton, United States.

What does Inflammasome Therapeutics do?

Inflammasome Therapeutics develops therapies for prevalent, degenerative diseases like Alzheimer’s disease and Parkinson's disease.

What stage is Inflammasome Therapeutics at?

Inflammasome Therapeutics is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 4, 2026.

MLA

"Inflammasome Therapeutics — Funding & Investors." VCBacked, May 4, 2026, https://www.vcbacked.co/company/inflammasome-therapeutics. Accessed June 3, 2026.

APA

VCBacked. (2026). Inflammasome Therapeutics — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/inflammasome-therapeutics

Wikipedia (cite web)

{{cite web |title=Inflammasome Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/inflammasome-therapeutics |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 4, 2026.